Spine devicemakers Medtronic, Orthofix and Globus Medical shared their most recent financial results for the second quarter of 2024 and the first quarter of fiscal year 2025.
Here is how their financials compare:
Net sales: $7.9 billion (+2.8%)
Net income: $1 billion (+32%)
Cranial and spinal sales: $1.1 billion (+4%)
Net sales: $629.7 million (+115.9%)
Net income: $31.8 million
Musculoskeletal sales: $592.9 million (+130.8%)
Net sales: $198.6 million (+6%)
Net loss: $33.4 million (+25%)
Musculoskeletal sales: $592.9 million (+130.8%)
SynerFuse is partnering with Velentium Medical to scale the SynerFuse e-TLIF implant, according to a March 21 news release. Velentium…
Here are four spinal devices that have earned FDA approval, as reported by Becker’s since Jan. 24:
Comments are closed.